Most US adults using social media report some health-related engagement with social media, according to a research letter published online June 30 in the Journal of the American Medical Association.

The FDA's acceptance of the NDA for AD109 marks a pivotal clinical milestone toward introducing the first oral pharmacotherapy designed to target the neuromuscular causes of obstructive sleep apnea.

The configuration of the initial pure tone audiogram is an independent predictor of complete recovery in idiopathic sudden sensorineural hearing loss (ISSNHL), ...

Prefontal transcranial pulse stimulation is associated with antidepressant effects, according to a study published online July 6 in JAMA Network Open. Penny Ping Qin, PhD, from The Hong Kong ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Exclusive breastfeeding may protect against attention-deficit/hyperactivity disorder (ADHD) in childhood, according to a study published online June 19 in Biological Psychiatry. Berit Skretting ...

A Prescription Drug User Fee Act target date of February 28, 2027 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...

The ELSPIRE trial evaluated patients with PBC who had an inadequate response or intolerance to UDCA and baseline ALP levels between 1 to 1.67 x ULN.

A deep learning model can identify hospitalized patients at risk for hypoglycemia within 24 hours, according to a study published online June 11 in npj Digital ...

About 31% of pediatric surgery patients receive an opioid prescription at discharge, according to a study published online June 23 in the Journal of the America ...

The triple combination regimen nearly doubled median progression free survival to 18.0 months compared with carfilzomib and dexamethasone alone in heavily pretreated patients.

Backed by phase 3 RINGSIDE data showing an 84% reduction in the risk of disease progression or death, the investigational agent moves ahead in the regulatory pipeline.